Find uplifting stories about heroes, innovations, and solutions
21 results for "biopharmaceuticals"
India just committed $1.2 billion to develop cutting-edge biologic medicines at home, aiming to treat cancer, diabetes, and autoimmune diseases without relying on imports. The five-year Biopharma Shakti program could transform how the nation tackles its biggest health challenges.
A Florida biopharmaceutical company just hit a major milestone in making regenerative medicine safer and more trustworthy. ZEO ScientifiX has now trained over 500 doctors on how to use stem cell therapies responsibly.
The number of self-made women billionaires worldwide has doubled in the past decade, reaching 150 leaders with a combined wealth of $470 billion. Three Indian women entrepreneurs rank among the global top 50, showcasing the growing power of women-led innovation.
After more than 700 deaths in Congo, the World Health Organization is testing the first treatments for a previously untreatable Ebola strain. Two promising drugs are now entering trials that could save thousands of lives.
University of Mississippi researchers created a customizable 3D-printed patch that helps chronic wounds heal faster using natural, biodegradable materials. The breakthrough could transform treatment for millions suffering from diabetic ulcers and pressure sores.
Patients with essential thrombocythemia finally have a new treatment option after nearly three decades. Taiwan just approved BESREMi, a therapy that could help thousands manage this rare blood disorder more effectively.
The World Health Organization just identified three promising experimental treatments for a challenging Ebola strain, bringing hope to affected communities in Central Africa. Multiple vaccines are also moving toward trials within months.
Researchers are moving fast to test two experimental treatments that could save lives in the current Ebola outbreak in the Democratic Republic of the Congo and Uganda. One therapy has already shown remarkable success in animals, offering real hope for patients.
Americans exposed to Ebola in Central Africa will now have access to a promising antibody treatment that has shown remarkable success in animal studies. The therapy offers new hope for protecting healthcare workers and others at risk during the current outbreak.
A global life sciences company just earned prestigious validation for its ambitious plan to slash emissions by up to 67% over the next decade. Lumanity's targets passed strict scientific review on the first try, setting a new standard for corporate climate action.
A French pharmaceutical company just acquired the maker of a groundbreaking childhood brain cancer treatment in a $2.5 billion deal. The move will help more kids worldwide access life-saving medicine.
Abu Dhabi is teaming up with global pharmaceutical company Sanofi to build a cutting-edge Vaccine Innovation Centre powered by artificial intelligence and mRNA technology. The facility will combine research, manufacturing, and pandemic preparedness under one roof to accelerate life-saving vaccine development.
A new million-dollar award will celebrate researchers who successfully translate breakthrough science into life-saving medicines. The prize aims to spotlight the often-overlooked step between discovery and getting treatments to patients who need them.
Small government grants are proving their worth in New Jersey, where startups turned $26 million in seed funding into $524 million in follow-up investment and nearly 1,800 new jobs. The results show how strategic early support helps young companies grow without forcing them to relocate.
New Jersey's innovation programs turned $25 million in grants into over half a billion dollars in private investment and nearly 1,800 new jobs. Early-stage startups in clean energy, AI, and biotech are now thriving in the Garden State thanks to strategic public support.
Health officials are racing experimental Ebola treatments to the Democratic Republic of Congo, where over 1,000 people have been infected in the fastest-moving outbreak ever recorded. The US just released a promising antibody drug for emergency use and clinical trials that could help end this crisis and prepare the world for future outbreaks.
Researchers are launching clinical trials for two promising Ebola treatments within weeks of an outbreak declaration, a breakthrough in pandemic response speed. One therapy saved five out of six sick monkeys in previous studies.
Five major companies didn't just meet their North Carolina job creation promises—they shattered them, creating nearly 750 more positions than pledged and paying salaries far above targets. Red Hat employees now earn 457% of the originally promised wage.
American universities and foundations just invested $1.3 billion to help startups use robotics and automation to bring manufacturing back to the U.S. The fund aims to rebuild domestic production and create supply chains that can weather any storm.
Major global companies are partnering with Singapore startups to transform waste into valuable resources while slashing carbon emissions. From robots sorting electronic waste to medical plastics paving roads, these collaborations are proving sustainability drives profit and growth.
Showing 20 of 21